Clinical Trial Update: Upfront Autologous HSCT Versus Immunosuppression in Early Diffuse Cutaneous Systemic Sclerosis [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing upfront autologous hematopoietic stem cell transplantation to immunosuppression in early diffuse cutaneous systemic sclerosis has comp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Cutaneous Systemic Sclerosis
• Systemic Sclerosis

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• MYCOPHENOLATE MOFETIL (MYCOPHENOLATE MOFETIL)

Snippet

Sponsor: UMC Utrecht | Conditions: Systemic Sclerosis, Systemic Scleroses, Diffuse | Phase 4 | Status: COMPLETED